Page 7 - Sanket Koul

CDSCO flags spurious liver drug, 169 others fail quality tests in April

CDSCO flags one batch of a liver drug as spurious and identifies 169 drugs and formulations as not of standard quality during April surveillance

Torrent Pharma Q4 profit falls 21.9% on high expenses despite revenue boost

Torrent Pharma's Q4 profit dropped 22% as JB Pharma integration costs pushed up expenses, despite strong growth in semaglutide-led revenues

CCI says hospitals not automatic monopolies over admitted patients

Max hospitals, Indraprastha among chains involved in series of 12 orders

Nissin leases 3.85 lakh sq ft warehouse near Ggn for ₹65 lakh rent

Logistics firm Nissin ABC has leased 3.85 lakh sq ft of warehouse space near Gurugram for five years amid rising demand for logistics assets

Max Healthcare Q4 PAT rises 7.2%, revenue rises 12% on occupancy

Max Healthcare reported a 7.2 per cent rise in fourth-quarter profit and 12 per cent revenue growth, aided by higher occupancy and international patient demand

How India's wellness drug market is catching Gen Z in the mirror

From online consults to doorstep drug deliveries, convenience is driving a new quick-fix healthcare mindset among Gen Z, which accounts for nearly 26% of India's population

Mankind Pharma Q4 PAT rises 30% on strong domestic biz, chronic push

Mankind Pharma posted a 30.4% rise in Q4FY26 profit, driven by strong demand for chronic therapies and OTC healthcare products

CDSCO asks states, UTs to monitor surrogate promotion for GLP-1 drugs

CDSCO has directed states and UTs to curb surrogate advertising of GLP-1 obesity drugs amid rising sales and aggressive awareness campaigns

AIOCD to go ahead with May 20 strike despite states opting out of protest

AIOCD will continue with its proposed nationwide strike against online pharmacies despite several state retail pharmacy associations opting out of the protest

Centre steps up Ebola preparedness after WHO alert in Central Africa

The Health Ministry has strengthened surveillance and preparedness measures after the WHO flagged an Ebola outbreak in parts of Congo and Uganda

Biosimilars could surpass generics in US mkt by early 2030s: Dr Reddy's CEO

Dr Reddy's CEO Erez Israeli says semaglutide, biosimilars and oncology will drive the company's next growth phase as it expands beyond traditional generics globally

Young Indians to benefit from easing of Dubai's visa-linked property rules

Dubai's decision to ease visa-linked property investment norms is expected to increase participation from young Indian buyers and mid-income professionals

Signature Global eyes launches worth ₹15,000 cr in FY27: Pradeep Aggarwal

Realty firm expects stronger sales momentum from branded residential projects and existing inventory in Gurugram during FY27

Developers seek extension of project timelines amid West Asia conflict

Credai seeks a blanket three to six-month extension for project deadlines, citing disruptions in material supplies and labour availability

DLF profit for March quarter 1% lower, revenue down 49% on lower income

Realty major reports weaker quarterly income even as annual sales bookings remained strong, led by luxury housing projects in Gurugram and Mumbai

NCLT allows withdrawal of insolvency process against ATS Le Grandiose

In an order dated May 5, the tribunal allowed withdrawal of CIRP following an amicable settlement with lenders under Section 12A of the Insolvency and Bankruptcy Code

Dr Reddy's Q4 PAT crashes 86% on generic Revlimid shock in US market

The fall was driven by weak US sales of Revlimid, offset only partially by growth in India, Europe, and emerging markets

India needs national common health dataset to create AI models: VK Paul

Former NITI Aayog member VK Paul said India needs a common health dataset and stronger primary healthcare systems to tackle rising non-communicable diseases

Scientists find new Covid-like virus in Thai bats with human infection risk

Researchers identified a sarbecovirus strain in Thai bats that may bind to human ACE2 receptors, though no human infections or community spread have been reported

Generic GLP-1 sales increase, but innovators retain market share

Over 25 versions of weight-loss drugs currently available in the market